Dirk Brehmer Selected Research

Dirk Brehmer Research Topics

8	Neoplasms (Cancer) 12/2021 - 12/2004
3	Carcinogenesis 03/2023 - 02/2015
2	Glioblastoma (Glioblastoma Multiforme) 01/2017 - 08/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2021
1	Hematologic Neoplasms (Hematological Malignancy) 12/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2015
1	Adenocarcinoma 10/2015
1	Lung Neoplasms (Lung Cancer) 04/2014
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2004
1	Hypersensitivity (Allergy) 10/2002
1	Melanoma (Melanoma, Malignant) 07/2002

4	Phosphotransferases (Kinase)IBA 01/2017 - 08/2005
3	Protein Kinases (Protein Kinase)IBA 12/2018 - 10/2015
2	MELK-T1IBA 12/2018 - 10/2015
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 10/2015 - 10/2015
2	Proteins (Proteins, Gene)FDA Link 08/2013 - 07/2002
1	Mitogen-Activated Protein KinasesIBA 03/2023
1	JNJ-64619178IBA 12/2021
1	RNA Splicing FactorsIBA 12/2021
1	ARS-1620IBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2016
1	LigandsIBA 01/2016
1	Adenosine Diphosphate (ADP)IBA 10/2015
1	Checkpoint Kinase 2IBA 10/2015
1	Adenylyl ImidodiphosphateIBA 10/2015
1	Adenosine Triphosphate (ATP)IBA 10/2015
1	Proto-Oncogene Proteins B-rafIBA 02/2015
1	AgarIBA 04/2014
1	DNA (Deoxyribonucleic Acid)IBA 08/2013
1	Small Interfering RNA (siRNA)IBA 08/2013
1	Threonine (L-Threonine)FDA Link 08/2005
1	Serine (L-Serine)FDA Link 08/2005
1	Tyrosine (L-Tyrosine)FDA Link 08/2005
1	orantinib (SU6668)IBA 08/2005
1	tyrosine receptor (receptor, tyrosine)IBA 08/2005
1	Protein Kinase InhibitorsIBA 08/2005
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2004
1	Imatinib Mesylate (Gleevec)FDA Link 12/2004
1	pyrimidineIBA 12/2004
1	IonsIBA 10/2002
1	InterleukinsIBA 07/2002
1	interleukin 20 (IL-20)IBA 07/2002
1	CytokinesIBA 07/2002
1	gamma-AIBA 07/2002
1	Interleukin-10 (Interleukin 10)IBA 07/2002
1	IL-TIF IL-10-related T cell-derived inducible factorIBA 07/2002

2	Therapeutics 08/2013 - 08/2005